New York State Teachers Retirement System (NYSTRS)’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.76M Buy
114,600
+4,095
+4% +$294K 0.02% 567
2026
Q1
$7.28M Sell
110,505
-3,995
-3% -$254K 0.01% 633
2025
Q4
$7.28M Hold
114,500
0.01% 649
2025
Q3
$6.29M Hold
114,500
0.01% 724
2025
Q2
$3.78M Buy
114,500
+400
+0.4% +$13.9K 0.01% 870
2025
Q1
$4.59M Buy
114,100
+200
+0.2% +$9.19K 0.01% 804
2024
Q4
$5.36M Buy
113,900
+100
+0.1% +$5.19K 0.01% 782
2024
Q3
$6.01M Buy
113,800
+1,600
+1% +$89.2K 0.01% 751
2024
Q2
$6.08M Sell
112,200
-1,300
-1% -$78.5K 0.01% 727
2024
Q1
$7.96M Sell
113,500
-18,065
-14% -$1.4M 0.02% 642
2023
Q4
$11M Hold
131,565
0.02% 505
2023
Q3
$3.88M Sell
131,565
-1,100
-0.8% -$36.6K 0.01% 873
2023
Q2
$4.33M Sell
132,665
-500
-0.4% -$18.5K 0.01% 839
2023
Q1
$4.69M Buy
133,165
+1,800
+1% +$73.4K 0.01% 800
2022
Q4
$6.02M Buy
131,365
+400
+0.3% +$17.2K 0.01% 701
2022
Q3
$6.34M Buy
130,965
+1,900
+1% +$91.4K 0.02% 656
2022
Q2
$5.07M Buy
129,065
+100
+0.1% +$4.03K 0.01% 757
2022
Q1
$4.75M Buy
128,965
+100
+0.1% +$3.55K 0.01% 834
2021
Q4
$5.87M Buy
128,865
+400
+0.3% +$15.4K 0.01% 782
2021
Q3
$4.59M Buy
128,465
+2,800
+2% +$82.4K 0.01% 866
2021
Q2
$2.49M Buy
125,665
+200
+0.2% +$4.7K 0.01% 1085
2021
Q1
$2.92M Sell
125,465
-3,500
-3% -$74.7K 0.01% 1021
2020
Q4
$2.68M Hold
128,965
0.01% 1016
2020
Q3
$2.79M Buy
128,965
+7,528
+6% +$176K 0.01% 918
2020
Q2
$2.86M Buy
121,437
+32,500
+37% +$609K 0.01% 902
2020
Q1
$1.05M Hold
88,937
﹤0.01% 1113
2019
Q4
$944K Buy
88,937
+500
+0.6% +$5.14K ﹤0.01% 1276
2019
Q3
$1.01M Buy
88,437
+2,900
+3% +$36.4K ﹤0.01% 1227
2019
Q2
$962K Buy
85,537
+619
+0.7% +$5.97K ﹤0.01% 1228
2019
Q1
$687K Buy
84,918
+301
+0.4% +$2.21K ﹤0.01% 1298
2018
Q4
$535K Buy
84,617
+1,725
+2% +$12.7K ﹤0.01% 1337
2018
Q3
$816K Hold
82,892
﹤0.01% 1300
2018
Q2
$688K Hold
82,892
﹤0.01% 1351
2018
Q1
$597K Hold
82,892
﹤0.01% 1363
2017
Q4
$676K Buy
82,892
+61,300
+284% +$696K ﹤0.01% 1355
2017
Q3
$313K Buy
21,592
+2,400
+13% +$32.8K ﹤0.01% 1466
2017
Q2
$232K Buy
+19,192
New +$267K ﹤0.01% 1513
2016
Q1
Sell
-2,900
Closed -$30K 1674
2015
Q4
$30K Buy
+2,900
New +$28.4K ﹤0.01% 1630

Other funds holding CYTK

New York State Teachers Retirement System (NYSTRS)'s CYTK Position: Q2 2026 in Review

New York State Teachers Retirement System (NYSTRS) increased its Cytokinetics (CYTK) stake by 3.7% in Q2 2026, buying an estimated $294K and bringing the position to 114,600 shares worth $9.76M. The position accounts for 0.02% of the portfolio, ranked #567.

New York State Teachers Retirement System (NYSTRS) first reported a position in CYTK in Q4 2015 and has held it in 38 quarters since. The position peaked at $11M in Q4 2023. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • New York State Teachers Retirement System (NYSTRS) held 114,600 shares of Cytokinetics worth $9.76M as of Q2 2026.
  • New York State Teachers Retirement System (NYSTRS) bought 4,095 Cytokinetics shares in Q2 2026, an estimated $294K.
  • Cytokinetics made up 0.02% of New York State Teachers Retirement System (NYSTRS)'s portfolio in Q2 2026, its #567 holding.
  • New York State Teachers Retirement System (NYSTRS) first reported a position in Cytokinetics in Q4 2015 and has held it in 38 quarters since.
  • New York State Teachers Retirement System (NYSTRS)'s Cytokinetics position peaked at $11M in Q4 2023.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q2 2026, filed 23 Jul 2026.